(PharmaNewsWire.Com, February 21, 2019 ) Synthetic Biology Marke, an interdisciplinary branch of biology and engineering, involves designing and constructing new devices, systems and biological parts as well as re-designing existing, natural biological systems. It has various application in the field of food & agriculture, medicine, and other areas. Technologies such as, gene synthesis, genome engineering and cloning and sequencing help the researchers to understand organization of natural biological systems and design new biological entities offering various advantages to humans.
Synthetic Biology Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Synthetic Biology Market To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
1. Thermo Fisher Scientific Inc. 2. Merck KGaA 3. Novozymes 4. Agilent Technologies 5. Amyris 6. GenScript 7. Integrated DNA Technologies, Inc. 8. Twist Bioscience 9. New England Biolabs 10. Synthetic Genomics Inc.
The synthetic biology market is estimated to grow at a CAGR of 28.2% during the forecast period from 2018 to 2025. The market for synthetic biology is estimated to reach US$ 56,044.9 Mn in 2025. The market for synthetic biology is witnessing a potential growth rate during the previous years and is expected to witness similar trend in the coming years. Global synthetic biology market is driven by extensive use of enzymes kits and other gene synthesis products in research institutes and academics. Additionally, rising demand for enzyme based kits and solutions required for gene manipulation and rising awareness about genetic engineering among the healthcare professionals in developed nations also accelerate the market growth. However, competition among existing market players may restrain the growth of the market.
Synthetic Biology Market – Global Analysis to 2025 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.
What our report offers:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Synthetic Biology Market - Highlights key business priorities in order to assist companies to realign their business strategies. - The key findings and recommendations highlight crucial progressive industry trends in the Synthetic Biology Market, thereby allowing players to develop effective long term strategies. - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
About Us The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
